Drugplain

ADYNOVATE

Antihemophilic Factor (Recombinant) PEGylated · KIT · Takeda Pharmaceuticals Amercia, Inc.

No Recall History
Plain English

ADYNOVATE is a kit containing antihemophilic factor (recombinant) pegylated. Manufactured by Takeda Pharmaceuticals Amercia, Inc..

Key Facts

Brand Name
ADYNOVATE
Generic Name
Antihemophilic Factor (Recombinant) PEGylated
NDC Code (Product)
0944-4626
Manufacturer
Takeda Pharmaceuticals Amercia, Inc.
Dosage Form
KIT
Marketing Status
Application #
BLA125566
Marketing Start
10/25/2016

Recall History

No Recall History

Frequently Asked Questions

What is ADYNOVATE used for?

ADYNOVATE contains Antihemophilic Factor (Recombinant) PEGylated. It is a kit taken as directed. Consult your doctor for specific uses.

Is ADYNOVATE a controlled substance?

ADYNOVATE is not classified as a controlled substance by the DEA.

What is the generic name for ADYNOVATE?

The generic name for ADYNOVATE is Antihemophilic Factor (Recombinant) PEGylated. There are 5 other brand versions of Antihemophilic Factor (Recombinant) PEGylated.

What is the NDC code for ADYNOVATE ?

The NDC (National Drug Code) for ADYNOVATE is 0944-4626, listed by Takeda Pharmaceuticals Amercia, Inc..

Product NDC

0944-4626

Package NDC

0944-4626-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)